Legend Biotech (LEGN) Interest & Investment Income (2024 - 2026)

Legend Biotech (LEGN) has 3 years of Interest & Investment Income data on file, last reported at $7.3 million in Q1 2026.

• Quarterly Interest & Investment Income fell 39.67% year-over-year to $7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.3 million (down 40.66% YoY) and the FY2025 annual result came in at $40.1 million, down 34.48% from the prior year.
• Interest & Investment Income retreated to $7.3 million in Q1 2026, from $7.9 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $17.0 million in Q2 2024 to a low of $7.3 million in Q1 2026.
• A 3-year average of $12.1 million and a median of $12.1 million in 2025 frame the typical range for Interest & Investment Income.
• The widest YoY moves for Interest & Investment Income: up 12.76% in 2025, down 42.34% in 2025.
• Tracing LEGN's Interest & Investment Income over 3 years: stood at $13.7 million in 2024, then sank by 42.34% to $7.9 million in 2025, then declined by 7.59% to $7.3 million in 2026.
• The last three Interest & Investment Income figures came in at $7.3 million (Q1 2026), $7.9 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.